This may explain results seen in this manuscript including increased NK and CD8+ T cell function, changes in CD4+ T cell recruitment, reduction in immune inhibitory receptor expression, and ligand availability on the tumor cells themselves. The gene discussed is CD8A; the disease is neoplasm.